Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Schizophrenia Congress highlights Article Hippocampal N-methyl-D-aspartate receptor hypofunction in first-episode psychosis pathophysiology Depression Article The application of artificial intelligence in the management of depression Bipolar Article Managing the burdens of bipolar disorder Migraine Congress highlights Article The impact of migraine on cognitive function